These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28660943)

  • 21. Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy.
    Lv Y; Cao Y; Li P; Liu J; Chen H; Hu W; Zhang L
    Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28671341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.
    Chen C; Hu H; Qiao M; Zhao X; Wang Y; Chen K; Guo X; Chen D
    Int J Pharm; 2015 Mar; 480(1-2):116-27. PubMed ID: 25615984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
    Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G
    J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
    Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y
    Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correction: A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
    Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao JW
    Nanoscale; 2018 Mar; 10(13):6212-6213. PubMed ID: 29595211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel CD44-targeting and pH/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis.
    Shi J; Ren Y; Ma J; Luo X; Li J; Wu Y; Gu H; Fu C; Cao Z; Zhang J
    J Nanobiotechnology; 2021 Jun; 19(1):188. PubMed ID: 34162396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Folate receptor-targeted multimodal fluorescence mesosilica nanoparticles for imaging, delivery palladium complex and in vitro G-quadruplex DNA interaction.
    Poshteh Shirani M; Rezaei B; Khayamian T; Dinari M; Karami K; Mehri-Lighvan Z; Hosseini Shamili F; Ramazani M; Alibolandi M
    J Biomol Struct Dyn; 2018 Dec; 36(16):4156-4169. PubMed ID: 29188757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondria-targeting folic acid-modified nanoplatform based on mesoporous carbon and a bioactive peptide for improved colorectal cancer treatment.
    Wang J; Zhang L; Xin H; Guo Y; Zhu B; Su L; Wang S; Zeng J; Chen Q; Deng R; Wang Z; Wang J; Jin X; Gui S; Xu Y; Lu X
    Acta Biomater; 2022 Oct; 152():453-472. PubMed ID: 36084923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation.
    Wang F; Yang S; Hua D; Yuan J; Huang C; Gao Q
    J Biomater Sci Polym Ed; 2016; 27(3):276-89. PubMed ID: 26578298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and Characterization of a Cancer-Targeted Drug Co-Delivery System Composed of Liposomes and Selenium Nanoparticles.
    Xuan G; Zhang M; Chen Y; Huang S; Lee I
    J Nanosci Nanotechnol; 2020 Sep; 20(9):5295-5304. PubMed ID: 32331095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug.
    Zhao F; Yin H; Li J
    Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
    Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
    Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells.
    Tong L; Chen W; Wu J; Li H
    Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanoscale polysaccharide derivative as an AEG-1 siRNA carrier for effective osteosarcoma therapy.
    Wang F; Pang JD; Huang LL; Wang R; Li D; Sun K; Wang LT; Zhang LM
    Int J Nanomedicine; 2018; 13():857-875. PubMed ID: 29467575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
    Shih WL; Yu FL; Chang CD; Liao MH; Wu HY; Lin PY
    Mol Carcinog; 2013 Oct; 52(10):800-12. PubMed ID: 22549898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma.
    Dong H; Yang X; Xie J; Xiang L; Li Y; Ou M; Chi T; Liu Z; Yu S; Gao Y; Chen J; Shao J; Jia L
    Biochem Pharmacol; 2015 Jan; 93(2):151-62. PubMed ID: 25522955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
    Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
    Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
    Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
    Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.